1.04
전일 마감가:
$1.03
열려 있는:
$1.02
하루 거래량:
2.94M
Relative Volume:
0.64
시가총액:
$124.95M
수익:
-
순이익/손실:
$-225.14M
주가수익비율:
-0.5306
EPS:
-1.96
순현금흐름:
$-192.27M
1주 성능:
+19.40%
1개월 성능:
+42.02%
6개월 성능:
+10.72%
1년 성능:
+22.09%
Invivyd Inc Stock (IVVD) Company Profile
명칭
Invivyd Inc
전화
(781) 819-0080
주소
1601 TRAPELO ROAD, WALTHAM
IVVD을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
IVVD
Invivyd Inc
|
1.04 | 215.66M | 0 | -225.14M | -192.27M | -1.96 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
447.43 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
722.01 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
336.26 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-04-05 | 업그레이드 | Guggenheim | Neutral → Buy |
2024-03-26 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2023-12-19 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
2023-05-01 | 개시 | H.C. Wainwright | Buy |
Invivyd Inc 주식(IVVD)의 최신 뉴스
Invivyd at Cantor Global Healthcare: Strategic Moves in COVID-19 Antibody Space - Investing.com
Can Invivyd Inc. hit a new high this monthMarket Activity Recap & Real-Time Volume Analysis - Newser
Custom watchlist performance reports with Invivyd Inc.Market Performance Summary & Capital Protection Trade Alerts - Newser
Will Invivyd Inc. see short term momentumPortfolio Value Report & Free Weekly Watchlist of Top Performers - Newser
How to monitor Invivyd Inc. with trend dashboardsQuarterly Portfolio Summary & Daily Entry Point Alerts - Newser
Will Invivyd Inc. bounce back from current supportRate Cut & Weekly Breakout Watchlists - Newser
Pattern recognition hints at Invivyd Inc. upsideWeekly Volume Report & AI Forecast for Swing Trade Picks - Newser
How to escape a deep drawdown in Invivyd Inc.Weekly Trading Summary & Fast Entry Momentum Trade Alerts - Newser
Volume spikes in Invivyd Inc. stock – what they meanJuly 2025 Closing Moves & Consistent Income Trade Ideas - Newser
What analysts say about Invivyd Inc. stockJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - khodrobank.com
Analyzing Invivyd Inc. with risk reward ratio chartsFed Meeting & Technical Pattern Alert System - Newser
Price momentum metrics for Invivyd Inc. explainedDay Trade & Weekly Return Optimization Plans - Newser
Chart based exit strategy for Invivyd Inc.Dollar Strength & Weekly Top Performers Watchlists - Newser
Live market analysis of Invivyd Inc.2025 Trading Volume Trends & Real-Time Volume Surge Alerts - Newser
What does recent volatility data suggest for Invivyd Inc.Market Performance Report & AI Enhanced Market Trend Forecasts - Newser
Applying Elliott Wave Theory to Invivyd Inc.July 2025 Retail & Risk Managed Investment Signals - Newser
Market reaction to Invivyd Inc.’s recent newsPortfolio Profit Report & Weekly Stock Performance Updates - Newser
Is Invivyd Inc. gaining market shareJuly 2025 Retail & Safe Entry Point Identification - khodrobank.com
Technical analysis overview for Invivyd Inc. stock2025 Year in Review & Technical Confirmation Trade Alerts - Newser
How high can Invivyd Inc. stock goEntry Point & AI Powered Market Entry Ideas - Newser
Analyzing recovery setups for Invivyd Inc. investors2025 Market Trends & Fast Entry Momentum Trade Alerts - Newser
Has Invivyd Inc. formed a bullish divergenceChart Signals & Community Trade Idea Sharing Platform - Newser
Is Invivyd Inc. impacted by rising ratesDay Trade & High Accuracy Buy Signal Tips - khodrobank.com
Will Invivyd Inc. stock go up soonJuly 2025 Sector Moves & Low Volatility Stock Recommendations - Newser
Will Invivyd Inc. stock recover after recent dropJuly 2025 Catalysts & AI Forecast for Swing Trade Picks - Newser
Long term hold vs stop loss in Invivyd Inc.2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - Newser
Using RSI to spot recovery in Invivyd Inc.M&A Rumor & AI Driven Price Forecasts - Newser
What are Invivyd Inc.’s technical support levelsJuly 2025 Breakouts & Safe Entry Trade Signal Reports - khodrobank.com
Trend analysis for Invivyd Inc. this weekWeekly Profit Recap & Free Long-Term Investment Growth Plans - Newser
Senior Manager/Associate Director, Marketing Waltham/Bostonwill consider remo at Invivyd - Mediabistro
Can machine learning forecast Invivyd Inc. recovery2025 Trade Ideas & Fast Gain Stock Tips - Newser
Long term hold vs stop loss in Invivyd Inc2025 Top Gainers & Scalable Portfolio Growth Methods - Newser
Using fundamentals and technicals on Invivyd Inc.July 2025 Highlights & Low Risk Investment Opportunities - Newser
Is Invivyd Inc. still worth holding after the dipJuly 2025 Review & Daily Chart Pattern Signals - Newser
What makes Invivyd Inc. stock price move sharplyQuarterly Growth Report & Weekly Top Performers Watchlists - Newser
Can momentum traders help lift Invivyd Inc.New Guidance & Safe Entry Trade Reports - Newser
Invivyd Inc (IVVD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Invivyd Inc 주식 (IVVD) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Lee Timothy Edward | Chief Commercial Officer |
Aug 18 '25 |
Sale |
0.65 |
20,013 |
13,012 |
88,987 |
Duke William E. | Chief Financial Officer |
Aug 19 '25 |
Sale |
0.57 |
29,643 |
16,796 |
49,344 |
Duke William E. | Chief Financial Officer |
Aug 18 '25 |
Sale |
0.65 |
20,013 |
13,012 |
78,987 |
Green Julie | Chief Human Resources Officer |
Aug 19 '25 |
Sale |
0.57 |
29,643 |
16,796 |
49,344 |
Green Julie | Chief Human Resources Officer |
Aug 18 '25 |
Sale |
0.65 |
20,013 |
13,012 |
78,987 |
Andersen Jill | Chief Legal Officer, Secretary |
Aug 19 '25 |
Sale |
0.57 |
49,402 |
27,991 |
84,446 |
Andersen Jill | Chief Legal Officer, Secretary |
Aug 18 '25 |
Sale |
0.65 |
33,352 |
21,685 |
133,848 |
Allen Robert D. III | Chief Scientific Officer |
Aug 19 '25 |
Sale |
0.57 |
27,420 |
15,536 |
53,068 |
Allen Robert D. III | Chief Scientific Officer |
Aug 18 '25 |
Sale |
0.65 |
18,512 |
12,037 |
80,488 |
자본화:
|
볼륨(24시간):